Matthew Arnold

机构：York University, University of Cambridge, AstraZeneca (Australia), Centre for Global Health Research, Médecins Sans Frontières · ORCID：0000-0001-6339-1115

发表论文 105 篇 · 总被引 2191 次 · h-index 24

代表论文

• Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses (2023 · The Lancet Diabetes & Endocrinology · 被引 77)
• Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real‐world settings: Insights from REVEAL ‐ CKD (2024 · European Journal of Clinical Investigation · 被引 27)
• Maintained renin–angiotensin–aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study (2024 · Clinical Kidney Journal · 被引 22)
• Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care (2024 · Nephrology Dialysis Transplantation · 被引 22)
• Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults (2024 · Open Forum Infectious Diseases · 被引 19)
• Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort (2024 · Advances in Therapy · 被引 17)